Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors

Journal of Neuropathology and Experimental Neurology

Volumn 66, Issue 10, 2007, Pages 944-954

  Ren, Zhi Ping ^a   Olofsson, Tommie ^a   Qu, Mingqi ^a,b,c   Hesselager, Göran ^a   Soussi, Thierry ^b,d   Kalimo, Hannu ^a,e   Smits, Anja ^a   Nistér, Monica ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SICHUAN UNIVERSITY   (China)

^d SORBONNE UNIVERSITÉ   (France)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Clonality; Glioma; Heterogeneity; Microdissection; Mutation; p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC MARKER; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; MALE; MICRODISSECTION; MOLECULAR GENETICS; PRIORITY JOURNAL;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MICRODISSECTION; MIDDLE AGED; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34948858931     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/nen.0b013e318156bc05     Document Type: Article

References (32)

1. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-25; discussion 226-29
2. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352:997-1003
3. Kleihues P, Cavenee WK. eds. World Health Organization Classification of Tumours, Pathology and Genetics: Tumours of the Nervous System. Lyon, France: IARC Press, 2000
4. Prados MD, Levin V. Biology and treatment of malignant gliomas. Semin Oncol 2000;27:1-10
5. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial tumors. J Neuropathol Exp Neurol 2005;64:479-89
6. 1-S transition control gene abnormalities. Cancer Res 2000;60:417-24
7. Kato H, Kato S, Kumabe T, et al. Functional evaluation of p53 and PTEN gene mutations in gliomas. Clin Cancer Res 2000;6:3937-43
8. Okamoto Y, Di Patre PL, Burkhard C, et al. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol (Berl) 2004;108:49-56
9. Walker C, du Plessis DG, Joyce KA, et al. Phenotype versus genotype in gliomas displaying inter- or intratumoral histologic heterogeneity. Clin Cancer Res 2003;9:4841-51
10. Hedrum A, Ponten F, Ren Z, et al. Sequence-based analysis of the human p53 gene based on microdissection of tumor biopsy samples. Biotechniques 1994;17:118-19; 122-24; 126-29
11. Ren ZP, Hedrum A, Ponten F, et al. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 1996;12:765-73
12. Ren ZP, Sallstrom J, Sundstrom C, et al. Recovering DNA and optimizing PCR conditions from microdissected formalin-fixed and paraffin-embedded materials. Pathobiology 2000;68:215-17
13. Ren ZP, Ahmadian A, Ponten F, et al. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am J Pathol 1997;150:1791-1803
14. Berg C, Hedrum A, Holmberg A, et al. Direct solid-phase sequence analysis of the human p53 gene by use of multiplex polymerase chain reaction and δ-thiotriphosphate nucleotides. Clin Chem 1995;41:1461-66
15. Leitner T, Halapi E, Scarlatti G, et al. Analysis of heterogeneous viral populations by direct DNA sequencing. Biotechniques 1993;15:120-27
16. Ponten F, Berg C, Ahmadian A, et al. Molecular pathology in basal cell cancer with p53 as a genetic marker. Oncogene 1997;15:1059-67
17. Hamroun D, Kato S, Ishioka C, et al. The UMD TP53 database and website: Update and revisions. Hum Mutat 2006;27:14-20
18. Kato S, Han SY, Liu W, et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 2003;100:8424-29
19. Soussi T, Kato S, Levy PP, Ishioka C. Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum Mutat 2005;25:6-17
20. Soussi T, Asselain B, Hamroun D, et al. Meta-analysis of the p53 mutation base for mutant p53 biological activity reveals a methodological bias in mutation detection. Clin Cancer Res 2006;12:62-69
21. Burger PC, Kleihues P. Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 1989;63:2014-23
22. Reifenberger G, Collins VP. Pathology and molecular genetics of astrocytic gliomas. J Mol Med 2004;82:656-70
23. Sidransky D, Mikkelsen T, Schwechheimer K, et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992;355:846-47
24. James CD, Carlbom E, Nordenskjold M, et al. Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 1989;86:2858-62
25. Coons SW, Johnson PC, Shapiro JR. Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in low grade human glioma. Cancer Res 1995;55:1569-77
26. Berkman RA, Clark WC, Saxena A, et al. Clonal composition of glioblastoma multiforme. J Neurosurg 1992;77:432-37
27. Biernat W, Aguzzi A, Sure U, et al. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcoma suggest a common origin of cells. J Neuropathol Exp Neurol 1995;54:651-56
28. Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosome 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995;54:91-95
29. Barnard R, Geddes J. The incidence of multifocal cerebral gliomas: A histological study of large hemisphere sections. Cancer 1987;60:1519-31
30. Batzdorf U, Malamud U. The problems of multicentric gliomas. J Neurosurg 1963;20:122-36
31. Russell D, Rubinstein L, eds. Pathology of Tumors of the Nervous System. London, UK: Edward Arnold, 1998
32. Nakamura M, Watanabe T, Yonekawa Y, et al. Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C→A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis 2001;22:1715-19